Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al
- PMID: 34340979
- DOI: 10.1136/annrheumdis-2021-220829
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al
Keywords: arthritis; rheumatoid; rituximab; vaccination.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli et al.Ann Rheum Dis. 2021 Oct;80(10):e167. doi: 10.1136/annrheumdis-2021-220997. Epub 2021 Aug 2. Ann Rheum Dis. 2021. PMID: 34340982 No abstract available.
Comment on
-
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response.Ann Rheum Dis. 2021 Oct;80(10):1355-1356. doi: 10.1136/annrheumdis-2021-220408. Epub 2021 May 6. Ann Rheum Dis. 2021. PMID: 33958323 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
